NALOXONE HYDROCHLORIDE .4 mg/mL (Naloxone Hydrochloride INJECTION, SOLUTION) .4 mg/mL

Naloxone Hydrochloride .4 mg/mL is an injectable solution used for emergency opioid overdose reversal. This multi-dose vial is suitable for intramuscular, intravenous, or subcutaneous administration.

Strength

.4 mg/mL

Pack Size

1 VIAL, MULTI-DOSE in 1 CARTON (36000-310-02) / 10 mL in 1 VIAL, MULTI-DOSE (36000-310-01)

Manufacturer / TM Owner

Baxter Healthcare Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Naloxone Hydrochloride is primarily used to counteract the effects of opioid overdose. It works by reversing the depressive effects of opioids on the central nervous system and respiratory system. This medication is often administered in emergency situations to restore normal breathing and consciousness in individuals experiencing opioid overdose.

Side Effects

Common effects of Naloxone Hydrochloride may include rapid reversal of opioid-induced respiratory depression and sedation. Some individuals may experience symptoms such as nausea, vomiting, or tremors. The effects are typically immediate but short-lived, requiring careful monitoring and potentially repeated doses.

Precautions & Warnings

Naloxone Hydrochloride should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow medical guidelines for use, as improper administration can lead to complications. Always consult healthcare professionals for guidance on handling and usage.

Avoid Interactions

Naloxone Hydrochloride may interact with other medications, particularly those that affect the central nervous system. It is important to be aware of potential interactions with opioids, sedatives, and other drugs that can cause respiratory depression. Always inform healthcare providers about all medications being taken to avoid adverse interactions.

Frequently Asked Questions

Naloxone Hydrochloride is used to reverse the effects of opioid overdose, restoring normal breathing and consciousness.

Naloxone Hydrochloride can be administered intramuscularly, intravenously, or subcutaneously, depending on the emergency situation.

Common side effects may include nausea, vomiting, tremors, and rapid reversal of opioid effects.

Naloxone Hydrochloride may interact with other medications, especially those affecting the central nervous system. Consult a healthcare provider for guidance.

Naloxone Hydrochloride should be stored according to the manufacturer's instructions to maintain its effectiveness and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.